Serum free thiols in type 2 diabetes mellitus: A prospective study.

Free sulfhydryl Glycemia Oxidative stress Thiols Type 2 diabetes

Journal

Journal of clinical & translational endocrinology
ISSN: 2214-6237
Titre abrégé: J Clin Transl Endocrinol
Pays: Netherlands
ID NLM: 101629335

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 02 11 2018
revised: 04 02 2019
accepted: 04 02 2019
entrez: 23 3 2019
pubmed: 23 3 2019
medline: 23 3 2019
Statut: epublish

Résumé

Oxidative stress is a driver in the development of type 2 diabetes (T2DM) complications. As thiols (R-SH) are oxidized by reactive oxygen and sulfur species, circulating concentrations may directly reflect systemic redox status. We hypothesized that high serum R-SH concentrations are a reflection of a favourable redox status and may therefore positively associate with disease status. R-SH were measured in serum of 943 T2DM outpatients (55% males, 65 years and HbA1c of 6.7% (50 mmol/mol)) with a follow-up period of 1.2 years. In the highest R-SH tertile patients were younger, more often men, had less microvascular complications, lower HbA1c and were more often treated nutritionally or with oral glucose-lowering drugs. Age- and sex adjusted hazard ratios for developing micro-, macro- or any complication plus death were 0.994, 0.992 and 0.993: even after adjustment for potential confounders. The Harrell's C statistic to predict microvascular complications or any complication plus death was higher in the models with R-SH than in those without R-SH. Although R-SH concentrations were associated with a favourable disease status, it did not add to the predictive capacity for long-term complications. Based on the current data R-SH seems unsuitable as a prognostic marker in T2DM.

Identifiants

pubmed: 30899672
doi: 10.1016/j.jcte.2019.100182
pii: S2214-6237(18)30136-4
pii: 100182
pmc: PMC6407140
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100182

Références

Arch Biochem Biophys. 1959 May;82(1):70-7
pubmed: 13650640
Stat Med. 2004 Mar 15;23(5):723-48
pubmed: 14981672
Tohoku J Exp Med. 2004 Jul;203(3):211-8
pubmed: 15240931
Diabetes. 2005 Jun;54(6):1615-25
pubmed: 15919781
Arch Iran Med. 2009 Mar;12(2):121-7
pubmed: 19249880
Mediators Inflamm. 2010;2010:453892
pubmed: 20182627
Eur J Pharmacol. 2010 Jun 25;636(1-3):8-17
pubmed: 20371238
Cell Signal. 2012 May;24(5):981-90
pubmed: 22286106
Free Radic Biol Med. 2013 Dec;65:244-253
pubmed: 23747983
J Diabetes Complications. 2013 Nov-Dec;27(6):548-52
pubmed: 24012111
Diabetes Res Clin Pract. 2014 Apr;104(1):1-52
pubmed: 24508150
BMC Endocr Disord. 2014 Mar 04;14:22
pubmed: 24593656
Biochim Biophys Acta. 2014 Sep;1840(9):2709-29
pubmed: 24905298
Redox Biol. 2015;4:180-3
pubmed: 25588755
Antioxid Redox Signal. 2015 Sep 20;23(9):734-46
pubmed: 25891126
J Drug Target. 2017 Feb;25(2):93-101
pubmed: 27356044
Pharmacol Res. 2016 Sep;111:452-458
pubmed: 27378569
Free Radic Biol Med. 2016 Oct;99:345-351
pubmed: 27554970
Saudi Pharm J. 2016 Sep;24(5):547-553
pubmed: 27752226
Eur J Gen Pract. 2017 Dec;23(1):83-90
pubmed: 28326866
Antioxid Redox Signal. 2017 Oct 1;27(10):684-712
pubmed: 28398072
J Lab Clin Med. 1993 Feb;121(2):257-62
pubmed: 8381845
Lifetime Data Anal. 1998;4(2):109-20
pubmed: 9658770

Auteurs

Emmelien E M Schillern (EEM)

University of Groningen, University Medical Centre, Department of Pathology and Medical Biology, Groningen, the Netherlands.

Andreas Pasch (A)

University of Bern, Department of Biomedical Research, Bern, Switzerland.

Martin Feelisch (M)

Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Femke Waanders (F)

Isala, Department of Internal Medicine, Zwolle, the Netherlands.

Steven H Hendriks (SH)

Isala, Diabetes Centre, Zwolle, the Netherlands.

Rik Mencke (R)

University of Groningen, University Medical Centre, Department of Pathology and Medical Biology, Groningen, the Netherlands.

Geert Harms (G)

University of Groningen, University Medical Centre, Department of Pathology and Medical Biology, Groningen, the Netherlands.

Klaas H Groenier (KH)

Isala, Diabetes Centre, Zwolle, the Netherlands.

Henk J G Bilo (HJG)

Isala, Department of Internal Medicine, Zwolle, the Netherlands.
Isala, Diabetes Centre, Zwolle, the Netherlands.
University of Groningen, University Medical Centre, Department of Internal Medicine, Groningen, the Netherlands.

Jan-Luuk Hillebrands (JL)

University of Groningen, University Medical Centre, Department of Pathology and Medical Biology, Groningen, the Netherlands.

Harry van Goor (H)

University of Groningen, University Medical Centre, Department of Pathology and Medical Biology, Groningen, the Netherlands.

Peter R van Dijk (PR)

Isala, Diabetes Centre, Zwolle, the Netherlands.
University of Groningen, University Medical Centre, Department of Internal Medicine, Groningen, the Netherlands.

Classifications MeSH